Company intelligence / Profile preview

AorTech International

Various (e.g., Dundee, Weybridge), United Kingdom

Ownership: Private
Development stage: Other

Overview

AorTech International is a company focused on the commercialization of its biostable polymer technology, Elast-Eon, used in medical devices. It has several product divisions, including AorTech Vascular and AorTech Heart Valve, and receives royalties from the licensing of its technology.

Therapeutic areas: CardiovascularNeurology
Modalities: Biostable PolymersMedical Devices
Industry: Chemicals & Materials

Partnerships

RUA Medical Devices (now part of RUA Life Sciences)Biomerics

Beyond the preview

Go deeper on AorTech International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AorTech International.

Explore the full profile